Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetic considerations for migraine therapies.
Capi M, Gentile G, Lionetto L, Salerno G, Cipolla F, Curto M, Borro M, Martelletti P. Capi M, et al. Among authors: cipolla f. Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1161-1167. doi: 10.1080/17425255.2018.1541452. Epub 2018 Nov 1. Expert Opin Drug Metab Toxicol. 2018. PMID: 30362834 Review.
Lasmiditan for the treatment of migraine.
Capi M, de Andrés F, Lionetto L, Gentile G, Cipolla F, Negro A, Borro M, Martelletti P, Curto M. Capi M, et al. Among authors: cipolla f. Expert Opin Investig Drugs. 2017 Feb;26(2):227-234. doi: 10.1080/13543784.2017.1280457. Expert Opin Investig Drugs. 2017. PMID: 28076702 Review.
Fremanezumab for the preventive treatment of migraine in adults.
Lionetto L, Curto M, Cisale GY, Capi M, Cipolla F, Guglielmetti M, Martelletti P. Lionetto L, et al. Among authors: cipolla f. Expert Rev Clin Pharmacol. 2019 Aug;12(8):741-748. doi: 10.1080/17512433.2019.1635452. Epub 2019 Jun 26. Expert Rev Clin Pharmacol. 2019. PMID: 31220963 Review.
Profiling lasmiditan as a treatment option for migraine.
Curto M, Cipolla F, Cisale GY, Capi M, Spuntarelli V, Guglielmetti M, Martelletti P, Lionetto L. Curto M, et al. Among authors: cipolla f. Expert Opin Pharmacother. 2020 Feb;21(2):147-153. doi: 10.1080/14656566.2019.1694004. Epub 2019 Nov 25. Expert Opin Pharmacother. 2020. PMID: 31766908 Review.
Ubrogepant for the treatment of migraine.
Curto M, Capi M, Cipolla F, Cisale GY, Martelletti P, Lionetto L. Curto M, et al. Among authors: cipolla f. Expert Opin Pharmacother. 2020 May;21(7):755-759. doi: 10.1080/14656566.2020.1721462. Epub 2020 Feb 3. Expert Opin Pharmacother. 2020. PMID: 32011192 Review.
Fremanezumab for the prevention of chronic and episodic migraine.
Lionetto L, Cipolla F, Guglielmetti M, Martelletti P. Lionetto L, et al. Among authors: cipolla f. Drugs Today (Barc). 2019 Apr;55(4):265-276. doi: 10.1358/dot.2019.55.4.2970909. Drugs Today (Barc). 2019. PMID: 31050694 Review.
Polyamines serum levels in episodic and chronic migraine.
Lionetto L, Guglielmetti M, Cipolla F, Bernardini S, Koehler BE, Capi M, De Bernardini D, Curto M, Manetti R, Nicoletti F, Simmaco M, Martelletti P. Lionetto L, et al. Among authors: cipolla f. Expert Rev Neurother. 2021 Feb;21(2):249-254. doi: 10.1080/14737175.2021.1862650. Epub 2020 Dec 21. Expert Rev Neurother. 2021. PMID: 33295216
24 results